Snoring can be so loud that medical intervention might be necessary, where a device is recommended to help him breathe better ...

Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...

Eating cheese lowers the risk of developing sleep apnea, a recent study found. Researchers said the essential nutrients in ...

An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...

Eli Lilly and Company (NYSE:LLY) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 5:15 PM ETCompany ParticipantsDave Ricks - Chairman ...

Experts say clinical obesity is more than a high BMI and instead is a disease in which excess body fat harms tissues, organs or doing daily activities.

Powers Health opened a new sleep clinic in the fast-growing town of Winfield. St. Mary Medical Center Sleep Medicine Services is now accepting patients at a new Winfield location in the Powers Health ...

Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to results of a retrospective study.The association between obesity and mortality ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.